Notes from the Field: Characteristics of Tetrahydrocannabinol–Containing E-cigarette or Vaping Products Used by Adults — Illinois September–October 2019

摘要

As of February 18, 2020, 2,807 patients hospitalized with e-cigarette, or vaping, product use–associated lung injury (EVALI) had been reported to CDC ( ). Nationwide, and in Illinois, approximately 80% of EVALI patients reported use of tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, products ( , ). The recent EVALI outbreak highlighted the limited availability of data on the characteristics of THC-containing e-cigarette, or vaping, products used in the United States.